These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11220534)

  • 1. The North American experience with the Ablate and Pace Trial (APT) for medically refractory atrial fibrillation.
    Wood MA; Kay GN; Ellenbogen KA
    Europace; 1999 Jan; 1(1):22-5. PubMed ID: 11220534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).
    Doshi RN; Daoud EG; Fellows C; Turk K; Duran A; Hamdan MH; Pires LA;
    J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1160-5. PubMed ID: 16302897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Left ventricular systolic function, paced QT dispersion, exercise tolerance and quality of life in long term follow up after ventricular pacemaker implantation (VVIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Małecka B; Bednarek J; Bigaj J
    Pol Merkur Lekarski; 2008 Mar; 24(141):190-4. PubMed ID: 18634282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
    Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
    J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial.
    Lim KT; Davis MJ; Powell A; Arnolda L; Moulden K; Bulsara M; Weerasooriya R
    Europace; 2007 Jul; 9(7):498-505. PubMed ID: 17491103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
    Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life].
    Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J
    Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.
    Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC
    Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pacemaker dependence in patients on ablate and pace therapy for atrial fibrillation.
    Occhetta E; Bortnik M; Dell'era G; Zardo F; Dametto E; Sassone B; Gabrieli L; Marino P
    Europace; 2007 Dec; 9(12):1119-23. PubMed ID: 17959682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation.
    Hsieh MH; Tai CT; Lee SH; Tsao HM; Lin YK; Huang JL; Chan P; Chen YJ; Kuo JY; Tuan TC; Hsu TL; Kong CW; Chang SL; Chen SA
    J Cardiovasc Electrophysiol; 2005 May; 16(5):457-61. PubMed ID: 15877612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic of the changes of the paced QT dispersion after ventricular pacemaker implantation (WIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Majewski J; Szczepkowski J; Dreher A; Bednarek J; Małecka B
    Przegl Lek; 2008; 65(2):61-7. PubMed ID: 18663902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.
    Chen L; Hodge D; Jahangir A; Ozcan C; Trusty J; Friedman P; Rea R; Bradley D; Brady P; Hammill S; Hayes D; Shen WK
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):19-27. PubMed ID: 17971146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of left ventricular pacing in patients with severe cardiac failure after atrioventricular node ablation and right ventricular pacing for permanent atrial fibrillation.
    Blanc JJ; Etienne Y; Gilard M
    Europace; 1999 Jan; 1(1):47-8. PubMed ID: 11220540
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of rhythm regularization and rate control in improving left ventricular function in atrial fibrillation patients undergoing atrioventricular nodal ablation.
    Verma A; Newman D; Geist M; Greenhut S; Laslop J; DeBellis L; Freeman MR; Dorian P
    Can J Cardiol; 2001 Apr; 17(4):437-45. PubMed ID: 11329544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the optimal ventricular pacing site in patients undergoing 'ablate and pace' therapy for permanent atrial fibrillation.
    Brignole M; Gammage M
    Europace; 2001 Apr; 3(2):153-6. PubMed ID: 11333055
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Piccinino C; Plebani L; Marino P
    J Am Coll Cardiol; 2006 May; 47(10):1938-45. PubMed ID: 16697308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.